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Ca2"-Induced Loss of Deformability and the Effects of Stomatocytogenic Reagents
on the Deformability Loss in Human Erythrocytes in Shear Flow
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ABSTRACT The Ca2"-induced loss of deformability in human erythrocytes and the recovery of the lost deformability by
stomatocytogenic reagents were investigated by means of a new flow electron paramagnetic resonance (EPR) spin label
method, which provides information on deformation and orientation characteristics of spin labeled erythrocytes in shear
flow. The Ca2"-induced loss of deformability is attributed mainly to the increase in intracellular viscosity resulting from
efflux of intracellular potassium ions and water (Gardos effect). Partial recovery of the lost deformability is
demonstrated in the presence of stomatocytogenic reagents, such as chlorpromazine, trifluoperazine, W-7, and
calmidazolium (R2457 1). The recovery can not be explained solely by suppression of the Gardos effect due to the
reagents. Incorporation of an optimal amount of the reagents into the membrane appears to compensate for the
membrane modification due to Ca2+ ions to restore a part of the lost deformability.
INTRODUCTION
Human erythrocytes maintain a low concentration of
intracellular Ca 2+ ions at -0.1-1 uM by the calcium pump
(Ca2`-Mg2`)-ATPase. When the intracellular Ca2" con-
centration is increased by a treatment with the calcium
ionophore A23187, a series of complex biochemical reac-
tions occurs including the activation of (Ca2+-Mg2+)-
ATPase by Ca2+-binding calmodulin (21, 28), the modifi-
cation of the metabolism and composition of membrane
lipids (1-3, 13), and the efflux of K+ ions and water (28,
30) (Gardos effect [16]). It is also known that with an
increase in the intracellular Ca 2+ ion concentration, the
cells suffer from a partial loss of the whole cell deformabil-
ity (11, 20, 22, 26, 40, 43). The erythrocyte deformability
is assumed to be generally determined by the following
factors: (a) physical properties of the membrane and
cytoskeleton (e.g., elasticity); (b) the state of the cytoplasm
(e.g., viscosity, hemoglobin concentration and aggrega-
tion); and (c) the geometry of the cell (e.g., shape, the
surplus of the membrane surface area of the cell relative to
its given volume) (14, 19, 23, 32, 35). Of the three factors,
the second has been proposed in the past to be the principal
mechanism of the Ca 2+-induced loss of deformability as
the result of the cell dehydration and the consequent high
internal viscosity (increase in hemoglobin concentration),
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because no loss of deformability was observed in a high
potassium medium in which dehydration and K+ effilux
are prevented (11, 20).
Since it was reported recently that some stomatocytog-
enic calmodulin inhibitors are able to suppress the Ca2+-
activated K+ efflux in both intact cells and inside-out
vesicles (27, 38, 39), it is expected that these reagents may
indeed suppress the Ca 2k-induced deformability loss with
concomitant inhibition of the Gardos effect.
In the present work, we used the stomatocytogenic
calmodulin inhibitors chlorpromazine (CPZ), trifluopera-
zine (TFP), W-7 (N-[6-aminohexyl]-5-chloro-1-naphthal-
ene sulfonamide), and calmidazolium (CMZ) (R24571,
1- [bis(p-chlorophenyl)methyl]-3- [2,4-dichloro-f-(2,4-
dichlorobenzyloxyl)phenethyl]imidazolinium chloride) in
an attempt to suppress the Ca 2k-induced K+ efflux, and
examine the effects of such reagents on deformability loss
induced by Ca 2+ loading. To measure the deformability of
red blood cells in laminar shear flow, we have utilized the
electron paramagnetic resonance (EPR) spin label tech-
nique, combined with a computer-regulated variable flow
device (23-25, 34, 35). It has been demonstrated experi-
mentally and theoretically that the change in the EPR
spectrum of a spin-labeled cell suspension observed in
shear flow as compared with that at rest is closely related
to the whole cell deformation and orientation (7-9, 23, 34,
35, 37). The method provides a means to assess the degree
of deformation and orientation as a function of volume
flow rate in intact as well as variously treated cells.
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Our results are consistent with the interpretation that
the Ca2"-induced deformability loss is mainly due to
dehydration of the cells, as has been proposed by Clark et
al. (11). Although the stomatocytogenic reagents indeed
partially restore the Ca"2-induced loss of deformability,
the suppression of the Gardos effect by the reagents was
found insufficient for complete explanation of the defor-
mability restoration. We propose, therefore, that some
other mechanism, such as a recovery of normal membrane
elasticity, may also be responsible for the observed partial
restoration. It is plausible, for example, that the reagents
serve to compensate for the Ca 2`-induced alteration of the
membrane lipid balance to restore a nearly normal mode of
bilayer-cytoskeleton interaction.
MATERIALS AND METHODS
Preparation of Erythrocyte Suspensions
Fresh heparinized (20 U/ml) human blood, from which buffy coat was
removed, was washed three times with an isotonic Hepes buffer (20 mM,
pH7.4 adjusted with NaOH) containing 140 mM NaCl and 5 mM KCI.
The cells were spin labeled with 5-doxyl stearic acid (Syva Co., Palo Alto,
CA) (Fig. 2 d) as described before (23). The final concentration of the
spin label in the measuring suspension was 3.2 x I0-5 M, at which level
no morphological changes were observed. The spin-labeled cells were
resuspended in the Hepes buffer, which contained 9%(wt/wt) dextran-40
(average molecular weight 40,000) (Sigma Chemical Co., St. Louis, MO)
at 35% hematocrit (Ht). The viscosity of the suspending medium was 5.6
x 10-3 Nsm -2. The final concentration of Ca 2+ in the measuring
suspension was within the range of 20-30 ,uM as measured by a calcium
electrode (model 93-29; Orion Scientific Instruments Corp., Orion
Research Inc., Pleasantville, NY) with an Orion lonalyzer (model 407).
All measurements were completed within 8 h from the start of the
preparation.
Calcium Loading
An appropriate portion of dimethylsufoxide solution (1 mg/ml) of the
Ca 2+ ionophore A23 187 (Calbiochem-Behring Corp., American
Hoechst, La Jolla, CA) was added to the cell suspension to make up a
final concentration between 10 and 20,uM.
Calmodulin Inhibitor Agents
Chlorpromazine hydrochloride was purchased from Sigma Chemical Co.,
calmidazolium (R24571) from Boehringer Mannheim Biochemicals (In-
dianapolis, IN), W-7 and W-5 from Seikagaku-Kogyo Co. (Tokyo,
Japan). Trifluoperazine dihydrochloride and its sulfoxide derivative were
the gifts of Smith Kline & French Laboratories (Philadelphia, PA). The
drugs were dissolved in dimethylsulfoxide at a concentration of 10-20
mM, and appropriate portions were added to the cell suspension before or
after Ca 2+ loading. Unless otherwise noted, the suspension was incubated
at 250C for 10 min before addition of A23187. For control experiments,
the drug solutions were replaced by dimethylsulfoxide.
Deformability Measurements
The whole cell deformability was measured by the flow-EPR method in a
flat quartz EPR cell connected to a syringe drive. The EPR spectral
change due to flow was measured at 250C using a Varian EC- 109 X-band
spectrometer with 100 KHz magnetic field modulation (modulation
amplitude 4 G), equipped with the Laboratory Data Acquisition System
built at the NIH Computer Division. The microwave power was kept at
40mW at which level no power saturation was observed under the present
experimental conditions. A computer regulated syringe drive was used to
create variable shear stress in the flat EPR cell (wall-to-wall gap 0.27 ±
0.01 mm, length 50 mm, width 8 mm), of which more details were
described elsewhere (24). The flat surface of the cell is oriented perpen-
dicularly to the magnetic field. After measuring the peak-to-trough
amplitude (h) (Fig. 1) in the absence of flow, the magnetic field was held
fixed at 3,370 G, at which point the spectral change Ah (Fig. 1) due to
flow is maximal. The field at which the spectral change is maximal
remains the same for a given type of spin label. The normalized spectral
change (A/hh) was used as an index to assess the degree of cell
deformation and orientation in shear flow. The volume flow rate was
increased stepwise from 0 to 0.1 ml/s in -3 min to obtain the spectral
change vs. flow rate curve. The volume flow rate of 0.1 ml/s corresponds
to the wall shear rate of 1,028 /s. Normally 5 ml of the cell suspension was
used.
Measurements of Hemoglobin
Concentration and Packed Cell Volume
The mean cellular hemoglobin concentration (MCHC) was determined
from the hematocrit and colorimetric measurement of cyanomethemoglo-
bin (42). The relative change of the packed cellular volume was measured
by the capillary centrifuge method.
Morphological Observations
Cells in suspension at the hematocrit of 35% were fixed in an equal
volume of 1% freshly prepared glutaraldehyde solution (Grade I, Sigma
Chemical Co., St. Louis, MO) in an isotonic Hepes buffer at room
temperature. The photomicrographs were taken using a Nikon Biophot
Model VBS microscope (Nihon Kogaku Co., Japan) equipped with
differential interference contrast optics. The morphological index was
calculated from 100 cell counts on a photograph according to Fujii et al.
(15). The positive and negative signs indicate echinocytes and stomato-
cytes, respectively.
RESULTS
Flow-induced Change in EPR Spectra of
Spin-labeled Cells
Fig. 1 a shows a typical EPR spectrum of the spin-labeled
erythrocytes in dextran solution in the absence of flow,
when the cells are randomly oriented in the suspension, as
illustrated in Fig. 2 a. Fatty acid spin labels are known to




FIGURE 1 EPR spectra of spin labled erythrocytes (a) in the absence(.....) and (b) presence ( ) of flow. Peak-to-trough amplitude (h)
andthe maximum difference between the two spectra (Ah) are indicated.





FIGURE 2 Schematic illustrations
of (a) random orientations of cells at
rest, (b) orientation and deformation
of cells in shear flow, (c) incorpora-
tion of spin labels into the lipid
bilayer, and (d) the spin label 5-






FIGURE 3 Dependence of Ah/h on flow rate for Ca 2+ -loaded cells at 0
(0), 8 (0), 20 (0), 35 (0) and 60 (-) min after addition of 1O,uM A23187
in the presence of 20 - 30 ,uM Ca 2+ ion.
aligned approximately perpendicularly to the membrane
surface (18) (Fig. 2, c and d). When the cells are flowing
through the flat cell, the red cells elongate and simulta-
neously orient along the flow direction at various angles
due to the flow induced shear stress (23) as shown in Fig. 2
b. The combined effect of deformation and orientation
causes a change in the spatial distribution of spin labels
with respect to the external magnetic field, resulting in a
spectral change as shown in Fig. 1 b. The increased
intensity in the two outer absorptions and the decrease in
the center peak indicate that there are more spin labels
with their long axes aligned parallel to the external mag-
netic field direction (or perpendicularly to the flow direc-
tion) (Fig. 2, c and d). Any motion of the cells slower than
the time scale of 10 s should not affect the EPR spectral
shape ( 18, 34). Previously, we have demonstrated that the
spectral changes are closely correlated with the ability of
the cells to deform and orient (23, 34), and the general
validity of the model for a flowing red cell was confirmed
by computer simulations of the EPR spectra measured at
varied flow rates (37). For characterizing the spectral
change, the normalized intensity difference Ah/h has been
used, where LA is the maximum spectral change occurring
at 3,370 G and h is the amplitude of the center peak in the
absence of flow, both in arbitrary units. Thus Ah/h may be
used for assessing the extent of the average deformation
and orientation independently of the signal intensities. In
our previous work, the spectral change was characterized
by a parameter l'/l, the ratio of the amplitudes of the low
field and the center absorption (37). That l'/l is linearly
related to Ah/h can be experimentally demonstrated (data
not shown). Further details and applications of the method
are described elsewhere (7-9, 23-25, 34, 35, 37). As shown
in Fig. 3, the observed parameter Ah/h in normal cells
generally rises steeply with the flow rate up to -0.02 ml/s
and gradually approaches a plateau around 0.1 ml/s.
There is some variance in Ah/h vs. flow rate characteristics
depending upon the blood specimen, but Ah/h values
measured in normal cells at 0.1 ml/s generally fall between
0.3 and 0.4. The profile of the individual run is highly
reproducible.
Effect of Ca2`-loading on Deformation and
Orientation
When the cells are incubated in the presence of Ca2+ ions
(30 ,uM) and Ca2" ionophore A23187, Ah/h decreases
with time (Figs. 3 and 4). At 35 min after addition of the
ionophore, nh/h is down to 0.11 at the flow rate of 0.1
ml/s, indicating that the cells become less deformable and
correspondingly less oriented. Few morphological changes
are seen in the Ca"2-loaded cells before flowing (morpho-
logical index + 0.04), but most of the cells are converted to
the stage I echinocytes (6) (morphological index +1.1)
after the flow, probably owing to an enhanced Ca 2+ ion
loading under shear stress (29). In the presence of 1 mM
ethylenediamine tetraacetate, the decrease in Ah/h did not
occur in the cell suspension containing Ca 2+ ion and the
ionophore, demonstrating that Ca 2+ ions are the agent
causing the deformability loss. While the time course of
Ah/h after Ca2+ loading depends somewhat upon the
individual blood specimen, a biphasic decrease of Ah/h
with time is observed as the general trend (Fig. 4). Fig. 4
also shows the simultaneously observed time course for the
change in the MCHC after addition of the Ca 2+ ionophore.
The increase in MCHC (or decrease in the cellular
volume) is inversely related to the change in Ah/h, suggest-
ing that the cell dehydration causes the deformability loss.
In a high K + medium (140 mM in place of Na +), neither
the decrease in Ah/h nor the increase in MCHC is
observed in the presence of the Ca 2+ ionophore. Thus, the
loss of the whole cell deformability in Ca2+-loaded cells
can be explained by the Gardos effect, by which the
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FIGURE 4 The time course of Ah/h (0) at the flow rate of 0.1 ml/s and
MCHC (-) after addition of 10,uM A23187.
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enhanced K + and water extrusion stimulated by the
elevated Ca2" level (1 1). The absence of decrease in Ah/h
in a high K + medium also demonstrates that the effect of
irreversible membrane protein cross-linking by Ca2+
mediated transglutaminase (12), if any, is negligibly small
under the present levels of Ca2+ loading.
Effects of Chlorpromazine, Trifluoperazine,
and W-7 on Ah/h vs. Flow Rate
Characteristics in Ca 2k-loaded Cells
Some calmodulin inhibitors are known to suppress the
Gardos effect (27, 38, 39). If the observed loss of the whole
cell deformability is due to the Gardos effect, the decrease
in Ah/h in Ca 2+-loaded cells is expected to be substantially
less in the presence of an inhibitor. We attempt to examine
the effects on the cell deformability of four inhibitors,
CPZ, TFP, W-7, and CMZ, which are also known to be
stomatocytogenic (33). The effect of CMZ, which behaves
differently from others, is described separately.
In the presence of 50 ,M CPZ, as shown in Fig. 5, the
Ah/h vs. flow rate curve, observed at 50 min after adding
the Ca 2+ ionophore, shows an extremely steep rise at the
beginning of flow and maintains a higher level than that in
the control (Ca 2k-loaded cells without CPZ) and, even
higher than in the intact cells in the low flow rate region
below -0.01 ml/s. No morphological changes were
observed photomicrographically before and after the flow
in the presence of 50 ,M CPZ (morphological index 0.00).
As the flow rate increases, Ah/h gradually decreases to the
level in the Ca"2-loaded cells without CPZ. This may be
due to an increase in the intracellular Ca2+ concentration
during the flow (29), competing against the drug effect.
Since no such enhancement of Ah/h is seen in intact
cells added with 50 ,M CPZ alone (data not shown), the
above described change should be specific to the situation
with an elevated cellular Ca 2+ level. There is also no
detectable stomatocyte formation in the present incubation
conditions when intact cells are treated with 50 ,M CPZ
alone. The recovery peaks at the flow rates 0.01-0.02 ml/s
almost independently of the drug concentration. No recov-
ery is observed at 200 uM CPZ (Fig. 5). The transient
recovery of Ah/h depends on the CPZ concentration as
<Q2;
O 0L05 0al
Flow Rate (ml Is)
FIGURE 5 Dependence of Ah/h on flow rate for intact cells (0),
Ca2"-loaded cells (E), and Ca2"-loaded cells in the presence of 50 gM
(&) and 200MuM (0) CPZ at 50 min after addition of 20 ,uM A23187.
shown in Fig. 6; the Ah/h measured at the flow rate of
0.015 ml/s goes through a maximum at [CPZ] = 50MM in
Ca2"-loaded cells. The morphological index at 100 ,M
CPZ before and after the flow was estimated to be -0.09
and 0.00, respectively. The decline of Ah/h at higher
concentrations may be due to nonspecific drug interactions
with the membrane, causing slight morphological changes.
The transformation to stomatocytes (morphological index
- 1) has been reported to occur at 320 ,M in normal cells
at Ht 35% (36). The MCHC value at 50 min after addition
of Ca 2+ ionophore remains constant at only a slightly
higher level (-41.2 ± 0.05 g/dl) in the presence ofCPZ (<
150 MuM), compared with 40.5g/dl without CPZ.
The time courses of Ah/h at the flow rate of 0.015 ml/s
and of MCHC, for Ca2"-loaded cells with and without
adding 50 uM CPZ, are shown in Fig. 7. The loss of
deformability due to the elevated Ca2, level is seen to be
partly restored by the addition of CPZ; the effect lasts at
least over the period of 1.5 h. In the ordinate scales for
Ah/h and MCHC as shown, the time courses for Ah/h and
MCHC appear to be inversely related to each other in
Ca2+-loaded cells without CPZ. On the other hand, the
extent of recovery of Ah/h due to CPZ in these cells is
considerably greater than that which is expected, on the
basis of the Gardos effect, from the relatively small
differences in MCHC between the systems in the presence
and absence of CPZ. The restoration of Ah/h was clearly
observed even when the difference in MCHC was negligi-
ble, for example, at 1 h after addition of the drug. Thus
the observed recovery can not be explained solely by the
suppression of the Gardos effect.
Similar results are obtained for TFP and W-7 (Fig. 8),
with the maximum recovery dose ranging between 50 and
80 ,uM. While the measured MCHC values depend upon
the blood specimens (typical values at 30 min after adding
the agent at 10 MuM being 43.1 ± 0.4 [41.2 without TFP]
and 44.8 ± 0.4 [43.5 without W-7] in grams per decaliter
for TFP and W-7, respectively), the individual MCHC in
the presence of the drug is found to be independent of the
drug concentrations. When a less effective calmodulin
antagonist and weaker stomatocytogenic reagent (33),
TFP sulfoxide or W-5 (a de-chloro derivative of W-7) is
used instead, a smaller deformation recovery is observed
(Fig. 8), indicating that the effect of TFP and W-7 in
recovery from the Ca 2"-induced deformability loss is
apparently correlated to their calmodulin inhibitory activ-
ity or stomatocytogenicity.
0.2
FIGURE 6 Dependence of Ah/h at
the flow rate of 0.015 ml/s on CPZ
concentration for Ca"2-loaded cells
at 50 min after addition of 20 ,M
A23187. The MCHC values for the
o50 7 , corresponding CPZ concentration
0 _50 10 150 remains constant at 41.2 g/dl.
CPZ concentration (PM)
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FIGURE 7 The time courses of Ah/h (circles) at 0.015 ml/s and MCHC
(triangles) in the absence (open) and the presence (solid) of 50MUM CPZ
after addition of 10 MM A23187. A typical result of three repeated
experiments.
Effect of Calmidazolium (CMZ) on Ah/h
vs. Flow Rate Characteristics in
Ca2+-loaded Cells
Calmidazolium (R2457 1) is known as a powerful inhibitor
of the calmodulin-dependent fraction of Ca 2+ transport
ATPase (17) and also a potent stomatocytogenic agent
(33). The concentration dependence of its effect on Ah/
h-flow rate characteristics is different from that with CPZ,
TFP, or W-7, as shown in Fig. 9. Namely, at 20,gM CMZ,
the Ah/h-flow rate curve shows the sharp rise at the
beginning of the flow as in other drugs, but at a higher dose
(75 gM CMZ) the sharp recovery in the low flow rate
region vanishes and instead, a marked recovery is observed
in the medium to high flow rate region. Thus, Ah/h values
at 75 ,M CMZ are lower than those at 20 ,uM below the
flow rate of 0.02 ml/s, above which the 75 ,uM dose gives
much higher recovery (Fig. 9). The entire feature of the
curve at 75 ,uM CMZ is similar to that in intact cells. The
concentration dependence of Ah/h at two flow rates 0.01
and 0.05 ml/s are shown in Fig. 10. The Ah/h at 0.01 ml/s
reaches a maximum at 20 ,M CMZ, while Ah/h at 0.05
ml/s continues to increase at least up to 80 qM.
Also different from the cases of CPZ, TFP and W-7, the
addition of CMZ above 10 ,uM causes a decrease in
MCHC in Ca2'-loaded cells (Fig.10). The increase in
Ah/h observed at the flow rate of 0.05 ml/s as a function of
the drug concentration appears to be inversely related to
the corresponding decrease in MCHC (Fig. 10). This is
another contrast to the other agents, in which MCHC
values were virtually independent of the drug concentra-
tions.
The time courses of Ah/h and MCHC at a low flow rate
FIGURE 8 Dependence of Ah/
h at the flow rate of 0.015 ml/s
0.2 on (a) TFP (0) (TFP sulfoxide
[^J) and (b) W-7 (0) (W-5 [A])
A / >concentrations in Ca 2+-loaded
cells. The MCHC values for the
corresponding concentrations re-
main constant at 43.1 and 44.8






FIGURE 9 Dependence of Ah/h on the flow rate for intact cells (0),
Ca2"-loaded cells (E), and Ca2"-loaded cells in the presence of 20 ,M
(tk) and 75 gM (0) CMZ at 30 min after addition of 10MgM A23187.
(0.015 ml/s) after addition of CMZ to Ca2+-loaded cells
are shown in Fig. 11. In the absence of CMZ, there is a
sharp decline in Ah/h during the first 10 min with
corresponding increase in MCHC, reflecting the elevated
Ca 2+ level. In the presence of CMZ, an appreciable
recovery in Ah/h appears over the time course of 1 h, and
concomitantly the MCHC stays consistently lower than in
the control, indicating a partial suppression of the Gardos
effect. Thus, the observed restoration of Ah/h by CMZ
may be attributed at least partly to the reduced level of the
Gardos effect. However, the other mechanism for restora-
tion such as the one expressed in the other agents may be
operating simultaneously, since the effect of CMZ on
Ah/h is not in proportion to that on MCHC (Fig. 1 1).
DISCUSSION
We have reconfirmed by the flow-EPR spin-label method
the loss of the whole cell deformability in Ca 2k-loaded
erythrocytes. The observations in which the time courses of
Ah/h and MCHC are inversely correlated even to the point
of mimicking the biphasic profiles in each other (Figs. 7
and I 1) and that such changes are completely suppressed
when the cells are suspended in a high K + medium, provide
a sufficient basis for concluding that the deformability loss
is the result of Ca2+-activated K + and water extrusion and
of the consequent increase in intracellular viscosity, as was
proposed by Clark et al. (1 1).
Since it has been demonstrated that the presence of
calmodulin causes a Ca 2k-dependent increase in the K+
permeability (30, 38) and the calmodulin antagonists at a
proper dose level block the K + extrusion (27, 39), the loss
of deformability in Ca2"-loaded cells is expected to be
restored to some extent by adding a calmodulin inhibitor.
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FIGURE 10 Dependence of Ah/h
at 0.01 (0) and 0.05 (0) ml/s, and
MCHC (A) on CMZ concentra-
tions at 30 min after addition of 10
MM A23 187.
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FIGURE 11 The time courses of Ah/h (circles) at the flow rate of 0.015
ml/s and MCHC (triangles) for Ca2`-loaded cells in the absence (open)
and presence (solid) of 20,uM CMZ.
presence of all the inhibitors tested, even though the
Gardos effect is never completely suppressed. Clear evi-
dence for the effect of the agent on cellular volume (or
MCHC) is obtained only with CMZ (Fig. 10), especially
at a high dose level. When the restoration of deformability
is the result of a partial suppression of H 20 efflux (i.e., a
less viscous cytosol), Ah/h should be evenly elevated over
the entire range of the flow rate as indeed is the case with
CMZ (Fig. 9). In the remaining reagents, CPZ, TFP, and
W-7, the effect on the cell volume in Ca2+-loaded cells is
only marginal, indicating that the Gardos effect is almost
fully activated at the selected dose levels. Nevertheless, the
deformability of Ca 2+-loaded cells is substantially restored
by the reagents, suggesting that some mechanism other
than the suppression of the Gardos effect may be operating
in the recovery. The dose rate per cell, e.g., of CPZ used in
the present work is estimated to be -1/30 of that used by
other workers (27) to suppress > 90% of K + extrusion
activity. Raising the dose level further in the present
experiments resulted in a lesser deformability restoration,
probably due to the onset of stomatocytosis (31, 33) and
other nonspecific disturbances. Thus, there seems to be an
optimal dose level for observing the restoration.
Except for the case of CMZ at a high dose level,
restorations are normally evident in the low shear rate
regions. This may be interpreted to indicate a change in
membrane properties, such as a lower modulus of elasticity
influencing the whole cell deformability. In the opposite
cases of a hardened membrane, either by cross-linking or
heat denaturation of spectrin, the reduction of Ah/h was
especially marked in the low to medium shear rate region,
and Ah/h gradually approaches the control level at high
shear rates (23, 32).
There have been suggestions concerning the membrane
deformability modifications associated with a low level
Ca 2+ loading, but no clear evidence has so far been
presented. In a study by the ektacytometry (1 1), the
immediate effect of a low level Ca 2+ loading on the
membrane property could not be clearly demonstrated
because of the combined effect of increased internal viscos-
ity and the decreased surface-to-volume ratio, but a slight
reduction in the initial slope of deformation index was
reported in some cases in high K+ media at high Ca2+
concentrations > 500 ,uM. Similarly, in Ca"2-treated
resealed ghosts, the reduction of the membrane deforma-
bility was demonstrated only at concentrations much
higher than 100 ,AM (20). The proper use of stomatocytog-
enic agents in the present work raised a strong possibility
that part of the deformability loss by Ca2+ ions may be
caused by some membrane property change that is masked
by the Gardos effect in Ca2+ loading alone.
A plausible explanation for the recovery effect, except
for the part in which suppression of the Gardos effect is
clearly responsible, may be based upon the activity of the
reagents as stomatocyte formers or as calmodulin inhibi-
tors. An enhanced intracellular Ca 2+ concentration, even
at a relatively low level, is known to induce a complex
variety of biochemical events involving several membrane
lipids and proteins (3). A relevant process in the present
context may be the breakdown of polyphosphoinositides,
which was shown to cause profound changes in the mem-
brane balance and has been implicated in the process of
echinocytosis (1, 4, 13). That incorporation of an echinocy-
togenic reagent into the membrane has an effect on the
rheological properties of the cell, especially in the low shear
characteristics, has been demonstrated (31). The deforma-
bility of an erythrocyte may be related to the balance of the
lipid bilayer through a close coupling between the lipid
bilayer and the cytoskeletal proteins (4, 19). In the absence
of the stomatocytogenic reagents, and at the Ca 2+ ion
concentrations used in the present work, echinocytosis is
latent before flow but becomes visible after flow. In the
presence of a stomatocytogenic reagent at an optimal dose
level, intercalation of the reagent into the membrane inner
layer is likely to compensate for the imbalance and restore
a near normal physical state, even though no explicit
morphological changes were observed.
If, on the other hand, it can be established that the
reagents used actually act as calmodulin inhibitors within
the cell, a possible explanation may be sought along the
line of the Ca 2k-dependent binding of calmodulin to
spectrin (5, 10, 21, 41), which may modify the visco-elastic
properties of the cytoskeleton. Regulation of the cell
morphology through Ca2+ ion-activated calmodulin, how-
ever, appears to be unlikely, since it has been shown that
CPZ causes stomatocytosis even in Ca 2k-depleted erythro-
cytes (10).
Receivedfor publication 9 January 1987.
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